{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:21:00Z","timestamp":1769012460483,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecules and Cells"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.14348\/molcells.2021.0076","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T03:34:33Z","timestamp":1632972873000},"page":"688-695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Asunaprevir, a Potent Hepatitis C Virus Protease Inhibitor, Blocks SARS-CoV-2 Propagation"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2659-6669","authenticated-orcid":false,"given":"Yun-Sook","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2386-076X","authenticated-orcid":false,"given":"Lap P.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2320-6514","authenticated-orcid":false,"given":"Gun-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5515-4582","authenticated-orcid":false,"given":"Sung-Geun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3380-6890","authenticated-orcid":false,"given":"Kwang-Soo","family":"Lyoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0392-2513","authenticated-orcid":false,"given":"Bumseok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8718-1793","authenticated-orcid":false,"given":"Soon B.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14348\/molcells.2021.0076_bib1","first-page":"e00221","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"Bio"},{"key":"10.14348\/molcells.2021.0076_bib2","first-page":"469","article-title":"Nonstructural NS5A protein regulates LIM and SH3 domain protein 1 to promote hepatitis C virus propagation","volume":"43","author":"Choi","year":"2020","journal-title":"Mol. Cells"},{"key":"10.14348\/molcells.2021.0076_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/clinchem\/hvaa029","article-title":"Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia","volume":"66","author":"Chu","year":"2020","journal-title":"Clin. Chem."},{"key":"10.14348\/molcells.2021.0076_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000507423","article-title":"COVID-19 outbreak: an overview","volume":"64","author":"Ciotti","year":"2019","journal-title":"Chemotherapy"},{"key":"10.14348\/molcells.2021.0076_bib5","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1128\/JVI.03488-13","article-title":"Coronaviruses: important emerging human pathogens","volume":"88","author":"Coleman","year":"2014","journal-title":"J. Virol."},{"key":"10.14348\/molcells.2021.0076_bib6","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.14348\/molcells.2021.0076_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.14348\/molcells.2021.0076_bib8","doi-asserted-by":"crossref","first-page":"576622","DOI":"10.3389\/fimmu.2020.576622","article-title":"The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens","volume":"11","author":"Duan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.14348\/molcells.2021.0076_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1208953","article-title":"Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C","volume":"368","author":"Gane","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.14348\/molcells.2021.0076_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect","volume":"465","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"10.14348\/molcells.2021.0076_bib11","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1021\/acsmedchemlett.0c00521","article-title":"Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2","volume":"11","author":"Ghahremanpour","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.14348\/molcells.2021.0076_bib12","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.14348\/molcells.2021.0076_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1126\/science.abb9332","article-title":"Rapid repurposing of drugs for COVID-19","volume":"368","author":"Guy","year":"2020","journal-title":"Science"},{"key":"10.14348\/molcells.2021.0076_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.14348\/molcells.2021.0076_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.coi.2013.08.004","article-title":"Drug repurposing: a better approach for infectious disease drug discovery?","volume":"25","author":"Law","year":"2013","journal-title":"Curr. Opin. Immunol."},{"issue":"D1","key":"10.14348\/molcells.2021.0076_bib16","doi-asserted-by":"crossref","first-page":"D708","DOI":"10.1093\/nar\/gkx932","article-title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)","volume":"46","author":"Lefkowitz","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.14348\/molcells.2021.0076_bib17","doi-asserted-by":"crossref","first-page":"11290","DOI":"10.1074\/jbc.M110.194472","article-title":"Hepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type IIIalpha and regulates viral propagation","volume":"286","author":"Lim","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.14348\/molcells.2021.0076_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12275-021-0470-8","article-title":"Adenosylhomocysteinase like 1 interacts with nonstructural 5A and regulates hepatitis C virus propagation","volume":"59","author":"Lim","year":"2021","journal-title":"J. Microbiol."},{"key":"10.14348\/molcells.2021.0076_bib19","doi-asserted-by":"crossref","first-page":"8777","DOI":"10.1128\/JVI.02533-10","article-title":"Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation","volume":"85","author":"Lim","year":"2011","journal-title":"J. Virol."},{"key":"10.14348\/molcells.2021.0076_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa1104430","article-title":"Preliminary study of two antiviral agents for hepatitis C genotype 1","volume":"366","author":"Lok","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.14348\/molcells.2021.0076_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","article-title":"The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections","volume":"15","author":"Machhi","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.14348\/molcells.2021.0076_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/BST20200670","article-title":"Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies","volume":"49","author":"Manfredonia","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"10.14348\/molcells.2021.0076_bib23","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J. Virol."},{"key":"10.14348\/molcells.2021.0076_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"key":"10.14348\/molcells.2021.0076_bib25","doi-asserted-by":"crossref","first-page":"34337","DOI":"10.1074\/jbc.M110.161802","article-title":"Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977","volume":"285","author":"Murakami","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.14348\/molcells.2021.0076_bib26","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/hep.24609","article-title":"Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1","volume":"54","author":"Nettles","year":"2011","journal-title":"Hepatology"},{"key":"10.14348\/molcells.2021.0076_bib27","doi-asserted-by":"crossref","first-page":"10073","DOI":"10.1128\/JVI.01707-15","article-title":"Pim kinase interacts with nonstructural 5A protein and regulates hepatitis C virus entry","volume":"89","author":"Park","year":"2015","journal-title":"J. Virol."},{"key":"10.14348\/molcells.2021.0076_bib28","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.14348\/molcells.2021.0076_bib29","doi-asserted-by":"crossref","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.14348\/molcells.2021.0076_bib30","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1021\/cb5006118","article-title":"Structural analysis of asunaprevir resistance in HCV NS3\/4A protease","volume":"9","author":"Soumana","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.14348\/molcells.2021.0076_bib31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2012.09.037","article-title":"Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options","volume":"58","author":"Suzuki","year":"2013","journal-title":"J. Hepatol."},{"key":"10.14348\/molcells.2021.0076_bib32","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.3390\/jcm9113777","article-title":"Drug repurposing approaches to combating viral infections","volume":"9","author":"Trivedi","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.14348\/molcells.2021.0076_bib33","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.14348\/molcells.2021.0076_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.14348\/molcells.2021.0076_bib35","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3390\/v2081803","article-title":"Coronavirus genomics and bioinformatics analysis","volume":"2","author":"Woo","year":"2010","journal-title":"Viruses"},{"key":"10.14348\/molcells.2021.0076_bib36","unstructured":"World Health Organization (2020). Coronavirus disease (COVID-19) situation reports. Retrieved December 8, 2020, from https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports\/"},{"key":"10.14348\/molcells.2021.0076_bib37","doi-asserted-by":"crossref","first-page":"114296","DOI":"10.1016\/j.bcp.2020.114296","article-title":"Repurposing existing drugs for the treatment of COVID-19\/SARS-CoV-2 infection: a review describing drug mechanisms of action","volume":"183","author":"Yousefi","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.14348\/molcells.2021.0076_bib38","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/S2589-7500(20)30192-8","article-title":"Artificial intelligence in COVID-19 drug repurposing","volume":"2","author":"Zhou","year":"2020","journal-title":"Lancet Digit. Health"}],"container-title":["Molecules and Cells"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/KSMCB\/2021\/044\/KSMCB044-09-07.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016847823002388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016847823002388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/pdf.medrang.co.kr\/KSMCB\/2021\/044\/KSMCB044-09-07.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T17:54:31Z","timestamp":1760896471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1016847823002388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1016847823002388"],"URL":"https:\/\/doi.org\/10.14348\/molcells.2021.0076","relation":{},"ISSN":["1016-8478"],"issn-type":[{"value":"1016-8478","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asunaprevir, a Potent Hepatitis C Virus Protease Inhibitor, Blocks SARS-CoV-2 Propagation","name":"articletitle","label":"Article Title"},{"value":"Molecules and Cells","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14348\/molcells.2021.0076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 THE AUTHORS. Published by Elsevier Inc on behalf of the Korean Society for Molecular and Cellular Biology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}